Call(WhatsApp Us)
+8618988990383Email Us
postmaster@laeyolabs.com广州市花都区花山镇华辉路18号
微观化妆品创意产业园E栋整栋European Union Regulation (EC) No. 1223/2009 is the backbone of cosmetics compliance in the EU — and baby care products such as lotions, wipes, and cleansing creams are no exception. This guide helps brand…
European Union Regulation (EC) No. 1223/2009 is the backbone of cosmetics compliance in the EU — and baby care products such as lotions, wipes, and cleansing creams are no exception. This guide helps brand owners and sourcing managers navigate PIF (Product Information File), CPSR (Cosmetic Product Safety Report), and CPNP (Cosmetic Products Notification Portal) obligations before entering the EU market.
Baby care formulas are treated as cosmetics under EU law if they are applied on skin, scalp, or hair for cleansing or protecting purposes. However, the sensitive user group (infants and toddlers) demands tighter substantiation, safety margins, and documentation rigor.
Below are the minimum components your manufacturer or compliance consultant should prepare.
| Document | Purpose | Owner | Evidence Type |
|---|---|---|---|
| Formula Breakdown (INCI + %) | Safety evaluation & notification | Manufacturer | Digital spec sheet |
| Raw Material Safety Data Sheets | Toxicological review | Supplier | SDS / COA |
| Stability & Compatibility Reports | Proof of shelf life, packaging fit | Lab | Test report |
| Microbiological Testing | Safety validation for infant use | Lab | Challenge test / micro limits |
| CPSR (Part A + B) | Legal safety assessment | Qualified assessor (toxicologist) | Signed report |
| Label Copy + Claim Support | Reg. 655/2013 compliance | Brand / QA | Claim substantiation dossier |
| GMP Declaration (ISO 22716) | Manufacturing compliance | Manufacturer | Certificate / audit report |
To keep your project compliant and efficient, align documents before mass production:
They follow the same Regulation (EC) No. 1223/2009 as adult cosmetics, but risk assessment and toxicological margins must account for infant sensitivity.
The “Responsible Person” based in the EU must keep the PIF accessible to authorities for 10 years after the last batch is marketed.
Yes, if intended for skin cleansing and containing cosmetic ingredients. If combined with disinfectant or biocidal claims, separate Biocidal Product Regulation (BPR) review applies.
Typically 10–20 working days after receiving all raw material data, stability, and safety tests.
Only if supported by documented testing showing negligible sensitization potential and reviewed under Reg. (EU) 655/2013 claim substantiation principles.
Next step: Ensure all compliance documents are built into your sourcing process before scaling production. Request a Quote from LAEYO Labs to start your EU-compliant baby care manufacturing project.